Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725642 | SCV000338340 | uncertain significance | not provided | 2017-11-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725642 | SCV000589641 | uncertain significance | not provided | 2018-09-14 | criteria provided, single submitter | clinical testing | The Y1494H variant in the DYSF gene has been reported previously in an individual with a limb-girdle muscular dystrophy or a Miyoshi myopathy diagnosis, and 5% dysferlin mRNA on muscle biopsy, who was also heterozygous for two additional DYSF variants; however segregation information was not reported (Cacciottolo et al., 2011). The Y1494H variant is observed in 34/51252 (0.066%) alleles from individuals of European background, in the ExAC dataset (Lek et al., 2016). The Y1494H variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret Y1494H as a variant of uncertain significance. |
Invitae | RCV000530924 | SCV000649697 | likely benign | Qualitative or quantitative defects of dysferlin | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000664797 | SCV000788812 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2016-12-16 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000530924 | SCV001298020 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Mayo Clinic Laboratories, |
RCV000725642 | SCV002541836 | uncertain significance | not provided | 2021-12-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000725642 | SCV003829645 | uncertain significance | not provided | 2022-06-16 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235177 | SCV003933721 | uncertain significance | not specified | 2023-05-05 | criteria provided, single submitter | clinical testing | Variant summary: DYSF c.4480T>C (p.Tyr1494His) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00044 in 247334 control chromosomes in the gnomAD database, including 1 homozygote (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in DYSF causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (0.00044 vs 0.0031), allowing no conclusion about variant significance. c.4480T>C has been reported in the literature in at least one individual affected with Limb-Girdle Muscular Dystrophy, however without strong evidence for causality (e.g., Cacciottolo_2011). This report does not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 21522182, 25898921). Eight ClinVar submitters (evaluation after 2014) have cited the variant with conflicting assessments, with 7 submitters classifying the variant as uncertain significance and one submitter classifying it as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Natera, |
RCV000664797 | SCV002082333 | uncertain significance | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2020-01-24 | no assertion criteria provided | clinical testing |